Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
KBI Biopharma has completed the acquisition of the assets of Elion Labs, a contract services organization in Louisville, CO.
read more
KBI Biopharma, Inc. (KBI) has signed an agreement with Merck & Co., Inc. (known as Merck in the United States and Canada) to acquire Merck’s microbial process development and manufacturing operations in Boulder, Colorado, effective May 1, 2014. Under...
read more
Thursday, November 14, 2019
Kayentis has announced the opening of a subsidiary in Japan, the world’s third largest pharmaceutical market.
read more
Wednesday, March 23, 2022
Kayentis has announced the launch of a fully integrated patient-centric platform that optimizes the management of hybrid and Decentralized Clinical Trials (DCT).
read more
Kayentis announces it is moving ahead on five new eCOA service projects with Emerging BioPharma (EBP) companies.
read more
Tuesday, January 10, 2023
Kayentis and ClinOne announced a strategic alliance. This collaboration combines Kayentis’ expertise in clinical trial data collection with ClinOne’s best-in-class consent management and patient engagement technology.
read more
Tuesday, November 05, 2024
Kashiv BioSciences announced the appointment of Dr. Sandeep Nilkanth Athalye as Global Chief Executive Officer. Dr. Athalye, a seasoned leader with over two decades of experience in strategic and operational roles within the global pharmaceutical ...
read more
Tuesday, November 29, 2022
Kaneka Corporation will manufacture and supply intermediates to Shionogi & Co., Ltd. for use in Xocova® (Ensitrelvir Fumaric Acid) Tablets 125mg, a drug for the treatment of SARS-Cov-2 infection.
read more
Tuesday, September 12, 2017
Kaneka Eurogentec announced its board has approved the construction of a new state of-the-art GMP facility adjacent to its current facility and equipped with a 2200 L fermenter.
read more
Thursday, September 22, 2022
Kaléo announced the execution of the first contract with the U.S. Department of Defense (DoD) for the procurement of the Rapid Opioid Countermeasure System (ROCS), a 10 mg Naloxone Auto-injector (naloxone hydrochloride injection) antidote for ultra-...
read more
JW Pharmaceutical and LEO Pharma announced they have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate, JW1601.
read more
Just Biotherapeutics announced they have entered into an agreement with Teva for the design and development of a high productivity (HP) biomanufacturing process.
read more
Wednesday, September 19, 2018
Just Biotherapeutics and Pandion Therapeutics announced they have entered into an agreement for the development and cGMP clinical manufacturing by Just of Pandion’s lead program.
read more
Wednesday, January 22, 2020
Evotec announced its wholly-owned Seattle-based subsidiary company Just – Evotec Biologics has established a collaborative relationship with OncoResponse.
read more
Juno Therapeutics, a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, and WuXi AppTec, an open-access R&D capability and technology platform company serving the pharmaceutical, ...
read more